Table 3.
Summary of results from comparative studies
| Sinoff and Werner, 2003 | Palmer et al., 2007 | Devier, current study | |
|---|---|---|---|
| Sample type | Clinic based study | Population based study | Clinic based study |
| Sample size | 42 anxiety, no cognitive impairment; 58 controls |
47 patients with MCI; 185 controls |
148 cognitive impairment (108 amnestic MCI +/−; 20 non-amnestic MCI, 20 no MCI) 63 controls |
| Age mean (SD) | Patients: 75.9 (5.0) Controls: 78.9 (6.3) |
Entire sample: 84.0 (5.1) | Patients: 67.1 (9.9) Controls: 65.7 (9.3) |
| Cognitive inclusion | No cognitive impairment | Patients with MCI | Patients with cognitive impairment |
| MMSE | MMSE ≥ 24 | Patients: MMSE < 24 Controls: MMSE > 24 |
Patients: MMSE ≥ 22 Controls: MMSE ≥ 27 |
| Anxiety scales | Sinoff’s Short Anxiety Screening Test |
Comprehensive Psychopatho- logical Rating Scale |
STAI |
| State/Trait | State | State | State and Trait |
| Average follow-up duration |
3.1 years | 3.4 years | 4.3 years evaluated annually |
| Findings | Anxiety predicted cognitive decline |
Anxiety predicted conversion from MCI to AD |
State anxiety did not predict conversion from MCI to AD; Higher Trait anxiety scores predicted a lower risk of conversion from MCI to AD |